Global Biopharmaceutical CMO & CRO Market by Source (Mammalian, Non-Mammalian), Service Type (Contract Manufacturing, Contract Research), Product, Scale of Operation, Therapeutic Applications - Forecast 2024-2030- Product Image

Sale

Global Biopharmaceutical CMO & CRO Market by Source (Mammalian, Non-Mammalian), Service Type (Contract Manufacturing, Contract Research), Product, Scale of Operation, Therapeutic Applications - Forecast 2024-2030

Report
184 Pages
March 2024
Region: Global
360iResearch™
ID: 5665842

UP TO €850EUR$875USD£733GBP OFF until Dec 31^st 2024

The Biopharmaceutical CMO & CRO Market size was estimated at USD 81.32 billion in 2023, USD 95.65 billion in 2024, and is expected to grow at a CAGR of 18.10% to reach USD 260.65 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biopharmaceutical CMO & CRO Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopharmaceutical CMO & CRO Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical CMO & CRO Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., arexel International Corporation, Baxter International Inc., Boehringer Ingelheim Biopharmaceuticals GmbH, Boehringer Ingelheim GmbH, Catalent, Inc., Charles River Laboratories International, Inc., Eurofins Scientific Limited, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., ICON Plc, KBI Biopharma, Inc., KEMWELL BIOPHARMA PRIVATE LIMITED, Laboratory Corporation of America Holdings, Lonza Group AG, NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC, Patheon Inc., Rentschler Biopharma SE, and Sterling Pharma Solutions.

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical CMO & CRO Market to forecast the revenues and analyze trends in each of the following sub-markets:

Source
- Mammalian
- Non-Mammalian
Service Type
- Contract Manufacturing
- Contract Research
Product
- Biologics
- Biosimilars
Scale of Operation
- Clinical
- Commercial
Therapeutic Applications
- Cardiovascular Diseases
- Infectious Disease
- Neurology
- Oncology
- Ophthalmology
- Respiratory Disorder

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Biopharmaceutical CMO & CRO Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopharmaceutical CMO & CRO Market?
What are the technology trends and regulatory frameworks in the Biopharmaceutical CMO & CRO Market?
What is the market share of the leading vendors in the Biopharmaceutical CMO & CRO Market?
Which modes and strategic moves are suitable for entering the Biopharmaceutical CMO & CRO Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Biopharmaceutical CMO & CRO Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising need for outsourced service in pharmaceutical and biotechnology sector
5.1.1.2. Potential demand for macromolecular therapeutics
5.1.1.3. Ongoing research and development activities in biopharmaceutical sector
5.1.2. Restraints
5.1.2.1. Issues pertinent to fewer outsource suppliers and less competition
5.1.3. Opportunities
5.1.3.1. Penetration of advanced technology in the biotechnology field
5.1.3.2. Emergence of Cell and Gene Therapies for Targeted Treatment
5.1.4. Challenges
5.1.4.1. Concern associated with accountability and quality control of CMO and CRO
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Biopharmaceutical CMO & CRO Market, by Source

6.1. Introduction
6.2. Mammalian
6.3. Non-Mammalian

7. Biopharmaceutical CMO & CRO Market, by Service Type

7.1. Introduction
7.2. Contract Manufacturing
7.3. Contract Research

8. Biopharmaceutical CMO & CRO Market, by Product

8.1. Introduction
8.2. Biologics
8.3. Biosimilars

9. Biopharmaceutical CMO & CRO Market, by Scale of Operation

9.1. Introduction
9.2. Clinical
9.3. Commercial

10. Biopharmaceutical CMO & CRO Market, by Therapeutic Applications

10.1. Introduction
10.2. Cardiovascular Diseases
10.3. Infectious Disease
10.4. Neurology
10.5. Oncology
10.6. Ophthalmology
10.7. Respiratory Disorder

11. Americas Biopharmaceutical CMO & CRO Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Biopharmaceutical CMO & CRO Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Biopharmaceutical CMO & CRO Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

15.1. Key Company Profiles
15.1.1. AbbVie, Inc.
15.1.2. arexel International Corporation
15.1.3. Baxter International Inc.
15.1.4. Boehringer Ingelheim Biopharmaceuticals GmbH
15.1.5. Boehringer Ingelheim GmbH
15.1.6. Catalent, Inc.
15.1.7. Charles River Laboratories International, Inc.
15.1.8. Eurofins Scientific Limited
15.1.9. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
15.1.10. ICON Plc
15.1.11. KBI Biopharma, Inc.
15.1.12. KEMWELL BIOPHARMA PRIVATE LIMITED
15.1.13. Laboratory Corporation of America Holdings
15.1.14. Lonza Group AG
15.1.15. NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC
15.1.16. Patheon Inc.
15.1.17. Rentschler Biopharma SE
15.1.18. Sterling Pharma Solutions
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. BIOPHARMACEUTICAL CMO & CRO MARKET RESEARCH PROCESS
FIGURE 2. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, 2023 VS 2030
FIGURE 3. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOPHARMACEUTICAL CMO & CRO MARKET DYNAMICS
FIGURE 7. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 8. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
FIGURE 10. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 12. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2023 VS 2030 (%)
FIGURE 14. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2023 VS 2030 (%)
FIGURE 16. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. BIOPHARMACEUTICAL CMO & CRO MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. BIOPHARMACEUTICAL CMO & CRO MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. BIOPHARMACEUTICAL CMO & CRO MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 6. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NON-MAMMALIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 9. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 12. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 15. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 18. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESPIRATORY DISORDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 40. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 41. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 45. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 67. CHINA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 68. CHINA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 69. CHINA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. CHINA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 71. CHINA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 72. INDIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 73. INDIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 74. INDIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. INDIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 76. INDIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 82. JAPAN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 84. JAPAN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. JAPAN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 86. JAPAN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 112. THAILAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 114. THAILAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. THAILAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 116. THAILAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. DENMARK BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 130. DENMARK BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. DENMARK BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 132. DENMARK BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 133. EGYPT BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 134. EGYPT BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 135. EGYPT BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. EGYPT BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 137. EGYPT BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 138. FINLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 139. FINLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 140. FINLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. FINLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 142. FINLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 143. FRANCE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. FRANCE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 147. FRANCE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 148. GERMANY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. GERMANY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 152. GERMANY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 158. ITALY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 159. ITALY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 160. ITALY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. ITALY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 162. ITALY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 173. NORWAY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 174. NORWAY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 175. NORWAY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. NORWAY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 177. NORWAY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 178. POLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 179. POLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 180. POLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. POLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 182. POLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 183. QATAR BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 184. QATAR BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 185. QATAR BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. QATAR BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 187. QATAR BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 203. SPAIN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. SPAIN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 207. SPAIN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 218. TURKEY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 219. TURKEY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 220. TURKEY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. TURKEY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 222. TURKEY BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SCALE OF OPERATION, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 233. BIOPHARMACEUTICAL CMO & CRO MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 234. BIOPHARMACEUTICAL CMO & CRO MARKET SHARE, BY KEY PLAYER, 2023
TABLE 235. BIOPHARMACEUTICAL CMO & CRO MARKET LICENSE & PRICING

Companies Mentioned

AbbVie, Inc.
arexel International Corporation
Baxter International Inc.
Boehringer Ingelheim Biopharmaceuticals GmbH
Boehringer Ingelheim GmbH
Catalent, Inc.
Charles River Laboratories International, Inc.
Eurofins Scientific Limited
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
ICON Plc
KBI Biopharma, Inc.
KEMWELL BIOPHARMA PRIVATE LIMITED
Laboratory Corporation of America Holdings
Lonza Group AG
NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC
Patheon Inc.
Rentschler Biopharma SE
Sterling Pharma Solutions

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 95.65 Billion
Forecasted Market Value ( USD ) by 2030	$ 260.65 Billion
Compound Annual Growth Rate	18.1%
Regions Covered	Global
No. of Companies Mentioned	18

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3277EUR$3,374USD£2,827GBP €3641EUR$3,749USD£3,141GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4151EUR$4,274USD£3,581GBP €4613EUR$4,749USD£3,979GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5025EUR$5,174USD£4,335GBP €5584EUR$5,749USD£4,817GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5900EUR$6,074USD£5,089GBP €6555EUR$6,749USD£5,655GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7648EUR$7,874USD£6,598GBP €8498EUR$8,749USD£7,331GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Biopharmaceutical CMO & CRO Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

Global Preclinical CRO Market by Services (Bioanalysis & DMPK Studies, Toxicology Testing), Application (Cardiovascular Disease, Dermatology, Gastrointestinal), End-User - Forecast 2023-2030

Preclinical CRO Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031

Global Contract Research Organization (CROs) Services Market by Type (Early Phase, Clinical, Lab, Consulting, Data Management), Therapeutic Area (Cancer, Infectious Disease, Neurology, Dermatology, Immunology, Hematology, Vaccines, CGT) - Forecast to 2029

Contract Research Outsourcing - Global Strategic Business Report